Pepcid Complete FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE 800 mg; 165 mg; 10 mg Tablet, Chewable
by JC World Bell Wholesale Co., Inc. · 6 BLISTER PACK in 1 BOX (50269-016-02) / 2 TABLET, CHEWABLE in 1 BLISTER PACK
NDC 50269-0016-02
🏷️ FDA NDC (as labeled)
50269-016-02
billing pads the product segment with a zero
This package
Contains2 tablet, chewable in 1 blister pack
Pack sizes3 compare ↓
OTC
Brand
On market
Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
50269-016-02
Product NDC
50269-016
11-digit billing NDC
50269001602
UNII
H0G9379FGK, NBZ3QY004S, 5QZO15J2Z8
Application #
NDA020958
SPL Set ID
39f7ee67-4eab-42b0-82fc-40dc8ce7666b
Established class (EPC)
Histamine-2 Receptor Antagonist
Mechanism of action
Histamine H2 Receptor Antagonists
DEA schedule
Non-controlled
Marketing category
NDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2020-09-01
Route
ORAL
Dosage form
TABLET, CHEWABLE
Substance
CALCIUM CARBONATE; MAGNESIUM HYDROXIDE; FAMOTIDINE
Why two NDCs?
The FDA registers this code as 50269-016-02 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 50269-0016-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Calcium compounds class.
Drug family (ATC)
Calcium compounds, Calcium
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerJC World Bell Wholesale Co., Inc.
Application holderKENVUE BRANDS LLC
FDA applicationNDA020958 (NDA)
Labeler code50269
First marketedSep 2020
Product typeHuman Otc Drug
Portfolio30 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
📗 Our plain-language guide HelloPharmacist
- This tablet combines two antacids — calcium carbonate and magnesium hydroxide — with famotidine, an acid reducer. The antacids work quickly to neutralize acid that's already in you...
- What exactly does this tablet do — how is it different from a regular antacid?
- You do need to chew it completely before swallowing — that's important. Don't swallow the tablet whole. Chewing it first is part of how it works and how it's meant to be used safel...
- Do I have to chew it, or can I just swallow it?
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Good Sense Dual Action Complete 10 mg/1; 800 mg/1; 165 mg 00113-0032-63 | L. | 25 tablets | $0.261 | — | Availability likely | — |
| Good Neighbor Pharmacy Dual Action Complete 10 mg/1; 800 mg/1; 165 mg 46122-0345-63 | Amerisource | 25 tablets | $0.261 | — | Availability likely | — |
| leader acid reducer complete 10 mg/1; 800 mg/1; 165 mg 70000-0416-01 | Cardinal | 25 tablets | $0.261 | — | Availability likely | — |
| leader acid reducer complete 10 mg/1; 800 mg/1; 165 mg 70000-0582-01 | Cardinal | 50 tablets | $0.261 | — | Availability likely | — |
| foster and thrive acid reducer antacid 10 mg/1; 800 mg/1; 165 mg 70677-1100-01 | Strategic | 25 tablets | $0.261 | — | Availability likely | — |
| injoy heartburn relief 10 mg/1; 800 mg/1; 165 mg 00113-6023-63 | L. | 25 tablets | — | — | FDA listed | — |
| Good Sense Dual Action Complete 10 mg/1; 800 mg/1; 165 mg 00113-7050-71 | L. | 50 tablets | — | — | FDA listed | — |
| Acid Reducer Complete 10 mg/1; 800 mg/1; 165 mg 00363-0511-71 | Walgreen | 50 tablets | — | — | FDA listed | — |
| Acid Reducer Complete 10 mg/1; 800 mg/1; 165 mg 00363-0713-33 | Walgreen | 60 tablets | — | — | Discontinued | — |
| Acid Reducer Complete 10 mg/1; 800 mg/1; 165 mg 00363-4036-71 | Walgreen | 50 tablets | — | — | FDA listed | — |
| acid reducer plus antacid 800 mg/1; 10 mg/1; 165 mg 11822-0223-00 | Rite | 50 tablets | — | — | Discontinued | — |
| Acid Reducer Plus Antacid 10 mg/1; 165 mg/1; 800 mg 11822-0500-01 | Rite | 25 tablets | — | — | FDA listed | — |
| Pepcid Complete 10 mg/1; 800 mg/1; 165 mg 16837-0246-25 | Kenvue | 25 tablets | — | — | FDA listed | — |
| Pepcid Complete 10 mg/1; 800 mg/1; 165 mg 16837-0298-12 | Kenvue | 100 tablets | — | — | FDA listed | — |
| Pepcid Complete 10 mg/1; 800 mg/1; 165 mg 16837-0891-25 | Kenvue | 25 tablets | — | — | FDA listed | — |
| Signature Care Acid Reducer Complete 10 mg/1; 800 mg/1; 165 mg 21130-0087-63 | Safeway | 25 tablets | — | — | FDA listed | — |
| signature care acid reducer complete 10 mg/1; 800 mg/1; 165 mg 21130-0546-63 | Safeway | 25 tablets | — | — | FDA listed | — |
| Acid Reducer Complete 10 mg/1; 800 mg/1; 165 mg 21130-0614-63 | Safeway | 25 tablets | — | — | FDA listed | — |
| acid reducer complete 10 mg/1; 800 mg/1; 165 mg 21130-0786-63 | Safeway | 25 tablets | — | — | FDA listed | — |
| DUAL ACTION Pepcid Complete 10 mg/1; 800 mg/1; 165 mg 29485-6522-02 | Lil' | 1 tablet | — | — | FDA listed | — |
| Dual Action Complete 10 mg/1; 800 mg/1; 165 mg 30142-0040-63 | Kroger | 25 tablets | — | — | FDA listed | — |
| Dual Action Complete 10 mg/1; 800 mg/1; 165 mg 30142-0213-71 | Kroger | 50 tablets | — | — | FDA listed | — |
| topcare dual action complete 10 mg/1; 800 mg/1; 165 mg 36800-0082-63 | Topco | 25 tablets | — | — | FDA listed | — |
| topcare dual action complete 10 mg/1; 800 mg/1; 165 mg 36800-0616-63 | Topco | 25 tablets | — | — | FDA listed | — |
| Dual Action Complete 10 mg/1; 800 mg/1; 165 mg 37808-0121-63 | H | 25 tablets | — | — | FDA listed | — |
| Dual Action Complete 10 mg/1; 800 mg/1; 165 mg 37808-0503-63 | H | 25 tablets | — | — | FDA listed | — |
| equaline complete dual action 10 mg/1; 800 mg/1; 165 mg 41163-0321-63 | United | 25 tablets | — | — | FDA listed | — |
| Dual Action Complete 10 mg/1; 800 mg/1; 165 mg 41250-0284-71 | Meijer | 50 tablets | — | — | FDA listed | — |
| Dual Action Complete 10 mg/1; 800 mg/1; 165 mg 41250-0690-71 | Meijer | 50 tablets | — | — | FDA listed | — |
| CareOne Acid Reducer Complete 10 mg/1; 165 mg/1; 800 mg 41520-0409-63 | American | 25 tablets | — | — | FDA listed | — |
| CareOne Acid Reducer Complete 10 mg/1; 800 mg/1; 165 mg 41520-0617-63 | American | 25 tablets | — | — | FDA listed | — |
| complete dual action 10 mg/1; 800 mg/1; 165 mg 42507-0321-50 | HyVee | 50 tablets | — | — | FDA listed | — |
| Equate Acid Reducer Complete 10 mg/1; 800 mg/1; 165 mg 49035-0321-63 | Wal-Mart | 25 tablets | — | — | FDA listed | — |
| Equate Acid Reducer Complete 10 mg/1; 800 mg/1; 165 mg 49035-0546-71 | Wal-Mart | 50 tablets | — | — | FDA listed | — |
| Pepcid Complete 800 mg/1; 165 mg/1; 10 mgthis 50269-0016-02 | JC | 2 tablets | — | — | FDA listed | — |
| Complete Acid Reducer 10 mg/1; 800 mg/1; 165 mg 51316-0588-63 | CVS | 25 tablets | — | — | FDA listed | — |
| Pepcid Complete 10 mg/1; 800 mg/1; 165 mg 53209-4001-02 | Morning | 1 tablet | — | — | FDA listed | — |
| DG Health acid reducer complete 10 mg/1; 800 mg/1; 165 mg 55910-0808-63 | Dolgencorp, | 25 tablets | — | — | FDA listed | — |
| dual action complete 10 mg/1; 800 mg/1; 165 mg 56062-0263-63 | Publix | 25 tablets | — | — | FDA listed | — |
| Acid Reducer Plus Antacid 10 mg/1; 165 mg/1; 800 mg 59779-0738-63 | CVS | 25 tablets | — | — | FDA listed | — |
| Acid Reducer Plus Antacid 10 mg/1; 800 mg/1; 165 mg 59779-0862-63 | CVS | 25 tablets | — | — | FDA listed | — |
| Pepcid Complete 165 mg/1; 10 mg/1; 800 mg 66715-6422-07 | Lil' | 1 tablet | — | — | FDA listed | — |
| Pepcid Complete, TRAVEL BASIX 165 mg/1; 10 mg/1; 800 mg 66715-6522-02 | Lil' | 1 tablet | — | — | FDA listed | — |
| Pepcid Complete, TRAVEL BASIX 165 mg/1; 10 mg/1; 800 mg 66715-7822-02 | Lil' | 1 tablet | — | — | FDA listed | — |
| Pepcid Complete 165 mg/1; 10 mg/1; 800 mg 66715-9822-02 | Lil' | 1 tablet | — | — | FDA listed | — |
| Pepcid Complete 10 mg/1; 800 mg/1; 165 mg 67751-0202-01 | Navajo | 1 tablet | — | — | FDA listed | — |
| Pepcid Complete 10 mg/1; 800 mg/1; 165 mg 70264-0034-01 | R | 50 tablets | — | — | FDA listed | — |
| Basic Care Dual Action Complete 10 mg/1; 800 mg/1; 165 mg 72288-0321-71 | Amazon.com | 50 tablets | — | — | FDA listed | — |
| Pepcid Complete 10 mg/1; 800 mg/1; 165 mg 73097-0017-25 | Savings | 1 tablet | — | — | FDA listed | — |
| Up And Up Dual Action Acid Reducer Antacid 10 mg/1; 800 mg/1; 165 mg 82442-0321-71 | Target | 50 tablets | — | — | FDA listed | — |
| Up and Up Dual Action Acid Reducer and Antacid 10 mg/1; 800 mg/1; 165 mg 82442-0546-71 | Target | 50 tablets | — | — | FDA listed | — |
About this product: this is the brand-name version. FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2020
On the market since
Sep 2020
📍
2026
Currently FDA-listed
6 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available
FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Pepcid Complete (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 34%
Female · 66%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 50269-0016-01 | 6 BLISTER PACK in 1 BOX (50269-016-01) / 1 TABLET, CHEWABLE in 1 BLISTER PACK | 2020-09-01 | Active |
| 50269-0016-02 You're viewing this | 6 BLISTER PACK in 1 BOX (50269-016-02) / 2 TABLET, CHEWABLE in 1 BLISTER PACK | 2020-09-01 | Active |
| 50269-0016-25 | 25 POUCH in 1 BOX (50269-016-25) / 1 TABLET, CHEWABLE in 1 POUCH | 2020-09-01 | Active |
Pack size FAQ
What quantity is in NDC 50269-0016-02?
NDC 50269-0016-02 is listed by the FDA — 6 blister pack in 1 box / 2 tablet, chewable in 1 blister pack.
What NDC number is used to bill for this package of Pepcid Complete FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE 800 mg; 165 mg; 10 mg Tablet, Chewable?
Bill NDC 50269-0016-02 — the 11-digit billing format is 50269001602. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 50269-016-02, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 50269-0016-02, written without dashes as 50269001602. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 50269-0016-02, the first segment (50269) is the labeler code FDA assigned to JC World Bell Wholesale Co., Inc.; the middle segment (0016) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (02) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by JC World Bell Wholesale Co., Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 1 tablet (50269-0016-01), 1 tablet (50269-0016-25). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
JC World Bell Wholesale Co., Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Use relieves heartburn associated with acid indigestion and sour stomach
⏱️ Dosage and Administration ▾
Directions adults and children 12 years and over: do not swallow tablet whole: chew completely to relieve symptoms, chew 1 tablet before swallowing do not use more than 2 chewable tablets in 24 hours children under 12 years: ask a doctor
⚠️ Warnings ▾
Warnings Allergy alert: Do not use if you are allergic to famotidine or other acid reducers Do not use if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor. with other acid reducers Ask a doctor before use if you have had heartburn over 3 months.
This may be a sign of a more serious condition. heartburn with lightheadedness, sweating, or dizziness chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness frequent chest pain frequent wheezing, particularly with heartburn unexplained weight loss nausea or vomiting stomach pain kidney disease Ask a doctor or pharmacist before use if you are taking a prescription drug. Antacids and acid reducers may interact with certain prescription drugs. Stop use and ask a doctor if your heartburn continues or worsens you need to take this product for more than 14 days If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
🧪 Active Ingredient ▾
Active ingredients (in each chewable tablet) Famotidine 10 mg Calcium carbonate 800 mg Magnesium hydroxide 165 mg Purposes Acid reducer Antacid
🧪 Inactive Ingredients ▾
Inactive ingredients cellulose acetate, corn starch, crospovidone, D&C red no. 7 calcium lake, dextrose excipient, FD&C blue no. 1 aluminum lake, FD&C red no. 40 aluminum lake, flavors, gum arabic, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, maltodextrin, mineral oil, modified starch, sucralose
🎯 Purpose ▾
Purposes Acid reducer Antacid
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.